Table I.
Criteria for selecting basonuclin target promoters
| Ensembl | human | mouse | h/m orthologs |
|---|---|---|---|
| Total promoter | 25111 | 16002 | |
| Promoter with at least one binding site | 24844 | 15828 | |
| Promoter with at least one binding module | 3293 | 2227 | |
| Human and mouse orthologous promoter containing the module | 662 | 466 | |
| Binding site and sequence alignment conservation | 21 | ||
| PCR possible | 12 | ||
| Verified by ChIP | 5 (42%) | ||
| DBTSS | human | mouse | h/m orthologs |
| Total promoter | 30964 | 19023 | |
| Promoter with at least one binding site | 30478 | 18676 | |
| Promoter with at least one binding module | 3684 | 2596 | |
| Human and mouse orthologous promoter containing the module | 528 | 529 | |
| Binding site and sequence alignment conservation | 12 | ||
| PCR possible | 9 | ||
| Verified by ChIP | 6 (67%) |